Key result
Higher pre-ablation TyG index linked to ~54% greater risk of AF recurrence.
Why the study?
AF recurrence after catheter ablation remains common, but the prognostic value of the triglyceride-glucose index, a surrogate of insulin resistance, had not been systematically evaluated in patients undergoing AF ablation.
Does a higher pre-ablation TyG index predict atrial fibrillation recurrence in patients undergoing catheter ablation?
Meta-Analysis (n=4,749)
Does a higher pre-ablation TyG index predict atrial fibrillation recurrence in patients undergoing catheter ablation?
Hazard Ratio: 1.54 (95% CI 1.21–1.97)
p-value: p=0.0004
An elevated pre-ablation TyG index is independently associated with an increased risk of atrial fibrillation recurrence after catheter ablation, suggesting its potential utility as a simple metabolic biomarker for pre-procedural risk stratification.
TyG index may aid post-ablation AF recurrence risk stratification; hypothesis-generating from observational data and should not yet change practice.
Background Atrial fibrillation (AF) recurrence after catheter ablation remains common. Insulin resistance contributes to atrial remodeling and may influence post-ablation outcomes. The triglyceride–glucose (TyG) index is a simple surrogate of insulin resistance; however, its prognostic value in patients undergoing AF ablation has not been systematically evaluated. Objectives To evaluate the association between pre-ablation TyG index and AF recurrence following catheter ablation. Methods A systematic review and DerSimonian–Laird random-effects meta-analysis of observational cohort studies were conducted, including studies reporting multivariable-adjusted hazard ratios (HRs) for the association between TyG index and AF recurrence. Analyses were performed using RevMan 5.4.1. The primary analysis pooled continuous TyG index estimates, while a secondary exploratory analysis pooled categorical comparisons (high vs. low TyG index). Heterogeneity and robustness were assessed through sensitivity analyses. Results Five studies comprising 4749 participants were included in the primary analysis. A higher pre-ablation TyG index was significantly associated with increased AF recurrence (pooled HR 1.54, 95% CI 1.21–1.97, P = 0.0004), with substantial heterogeneity. Sensitivity analysis confirmed robustness of this association. The secondary categorical analysis, including two studies (high vs. low TyG tertiles), did not show a statistically significant association with AF recurrence (pooled HR 1.54, 95% CI 0.95–2.50, P > 0.05). However, methodological differences and analytic constraints are more likely than absence of a true association. Conclusions A higher pre-ablation TyG index as a continuous variable is independently associated with AF recurrence after catheter ablation. Categorical TyG analyses did not demonstrate a significant association, although methodological and analytical limitations make it inconclusive. Nevertheless, TyG index may represent a promising marker for risk stratification; however, given the predominantly Chinese cohorts, these findings should be interpreted with caution and support the need for further studies for external validation before incorporation of TyG index into pre-procedural risk stratification models.
No takes yet. Share an insight, caveat, or question.
Mohsin et al. (2026) conducted a meta-analysis in Atrial fibrillation (n=4,749). Pre-ablation triglyceride-glucose (TyG) index vs. Lower TyG index was evaluated on Atrial fibrillation recurrence (HR 1.54, 95% CI 1.21-1.97, p=0.0004). A higher pre-ablation TyG index, modeled as a continuous variable, was significantly associated with an increased risk of atrial fibrillation recurrence following catheter ablation (HR 1.54).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: